Confirmation

EP3908276

METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

  • :
    EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi
  • :
    8.1.2020
  • :
    11.6.2025
  • :
    20703633.6
  • :
    7.1.2040
  • :
    7.1.2026
  • :
    METHODS OF TREATING CONDITIONS RELATED TO THE S1P1 RECEPTOR

8.1.2020
11.6.2025
7.1.2026
  • :
    Arena Pharmaceuticals, Inc.
  • :
    66 Hudson Boulevard East, New York, NY 10001-2192, US
  • :
    NAIK, Snehal
  • :
    San Diego, California 92130, US
  • :
    201962789937 P
  • :
    8.1.2019
  • :
    US
  • :
    US2020012783
  • :
    8.1.2020
  • :
    A61K 31/404, A61P 37/00